TP53 and cancer: Furthermore, p53 signaling and Wnt/β-catenin pathways, both of which are involved in cell survival and oncogenic transformation, were downregulated in response to LA-CB1, further supporting the compound’s role in inducing apoptosis and inhibiting proliferative signaling in cancer cells.